Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBPHealthcare · Biotechnology
+0.00%$4.22
AH$4.22+0.00%vs close
Mkt Cap$81.91M
Float16.96M
O/S19.41M
Vol
$ Vol
RVOL
Inst Own71.2%
SI16.0%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$78.54M
Total Assets$168.19M
Free Cash Flow-$64.5M
Debt & Equity
Debt 1%
Equity 99%
Total Debt$1.63M
Total Equity$147.5M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:30Reverse splitFeb 14, 202330 shares → 1
Balance Sheet Details
Assets$168.19M
Liabilities$20.69M
Accounts Receivable$1.5M
Accounts Payable$2.21M
Inventory$0
PP&E (Net)$1.24M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $882K | $3.94M | $36.14M | $4.82M | $2.44M | $1.91M | $648K | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | -77.6% | -89.1% | 649.5% | 97.6% | 27.7% | 194.8% | - | - | - | - |
| Cost of Revenue | $0 | $600K | $0 | $1.49M | $1.64M | $0 | $89.6M | $48.61M | $26.04M | $15.44M | $5.89M | $1.26M | $0 | $0 |
| Gross Profit | $0 | -$600K | $0 | -$1.49M | -$758K | $3.94M | -$53.46M | -$43.79M | -$23.6M | -$13.53M | -$5.24M | -$1.26M | $0 | $0 |
| Gross Margin | - | - | - | - | -85.9% | 100.0% | -147.9% | -908.1% | -967.1% | -707.6% | -808.2% | - | - | - |
| Research and Development | $70.09M | $32.22M | $31.17M | $16.14M | $36.45M | $98.27M | $89.6M | $48.61M | $26.04M | $15.44M | $5.89M | $1.26M | $211K | $575 |
| Selling, General, and Administrative | $15.21M | $16.5M | $13.91M | $18.7M | $20.43M | $28.48M | $23.64M | $12.96M | $8.96M | $6.46M | $3.61M | $1.39M | $347K | $289 |
| Other | $0 | -$600K | $0 | -$1.49M | -$1.64M | $0 | -$89.6M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $85.31M | $48.12M | $45.08M | $33.35M | $55.23M | $126.75M | $23.64M | $61.57M | $35M | $21.9M | $9.5M | $2.65M | $557K | $827 |
| Operating Income (EBIT) | -$85.31M | -$48.72M | -$45.08M | -$34.84M | -$55.99M | -$122.81M | -$77.1M | -$56.75M | -$32.56M | -$19.99M | -$8.85M | -$2.65M | -$557K | -$824 |
| Operating Margin | - | - | - | - | -6350.1% | -3119.2% | -213.3% | -1176.8% | -1334.4% | -1045.6% | -1365.5% | - | - | - |
| Interest Expense | $0 | $1.87M | $2.92M | $2.13M | $1.83M | $1.03M | $0 | $0 | $0 | $0 | $2K | $24K | $45K | $0 |
| Interest Income | $5.53M | $6.31M | $0 | $0 | $0 | $0 | $1.23M | $983K | $183K | $477 | $3K | $2K | $754 | $60 |
| Other Income (Expense) | $6.77M | $8.51M | $474K | -$7.51M | $10.35M | $11.54M | $5.65M | $1.08M | $141K | -$14K | $3K | $107K | -$45K | -$63 |
| Income Before Tax (EBT) | -$78.54M | -$40.21M | -$44.6M | -$42.35M | -$45.64M | -$111.27M | -$71.45M | -$55.67M | -$32.42M | -$20M | -$8.85M | -$2.54M | -$602K | -$887 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $14K | $2K | $24K | $0 | $0 |
| Net Income | -$78.54M | -$40.21M | -$44.6M | -$55.83M | -$45.55M | -$111.27M | -$71.45M | -$55.67M | -$32.42M | -$20M | -$8.85M | -$2.54M | -$602K | -$887 |
| Net Income Margin | - | - | - | - | -5166.4% | -2826.1% | -197.7% | -1154.5% | -1328.6% | -1046.3% | -1365.1% | - | - | - |
| Supplementary Data | ||||||||||||||
| EPS | -5.90 | -3.68 | -10.31 | -10.15 | -11.13 | -42.72 | -33.55 | -29.30 | -19.38 | -14.58 | -8.47 | -3.78 | -0.70 | -3.82 |
| Diluted EPS | -5.90 | -3.68 | -10.31 | -10.15 | -11.13 | -42.72 | -33.55 | -29.30 | -19.38 | -14.58 | -8.47 | -3.78 | -0.70 | -3.82 |
| Weighted Average OS | 13.32M | 10.91M | 4.33M | 4.17M | 4.10M | 2.60M | 2.13M | 1.90M | 1.67M | 1.37M | 1.05M | 671,995 | 860,064 | 232 |
| EBITDA | -$78.3M | -$37.75M | -$40.1M | -$38.73M | -$42.17M | -$121.12M | -$75.87M | -$56.25M | -$32.31M | -$19.9M | -$8.81M | -$2.64M | $0 | $824 |
| EBITDA Margin | - | - | - | - | -4782.9% | -3076.2% | -209.9% | -1166.5% | -1324.0% | -1041.0% | -1358.7% | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $28.49M | $17.2M | $13.72M | $17M | $25.01M | $85.43M | $31.75M | $41.75M | $62.54M | $14.99M | $12.34M | $6.26M | $303K | $542 |
| Short-Term Investments | $134.78M | $131.86M | $7.18M | $42.19M | $72.64M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $163.94M | $149.06M | $20.91M | $59.2M | $97.65M | $85.43M | $31.75M | $41.75M | $62.54M | $14.99M | $12.34M | $6.26M | $303K | $542 |
| Accounts Receivable | $1.5M | $0 | $0 | $0 | $0 | $2.58M | $2.68M | $0 | $0 | $1.33M | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $350K | -$2.68M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $1.51M | $3.91M | $192K | $192K | $192K | $0 | $2.68M | $2.49M | $159K | $150K | $0 | $0 | $0 | $2 |
| Total Current Assets | $166.95M | $152.98M | $23.55M | $60.18M | $100.2M | $92.07M | $38.15M | $44.24M | $65.5M | $17.4M | $12.71M | $6.53M | $306K | $545 |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $1.24M | $2.52M | $4.04M | $5.5M | $7M | $9.32M | $10.9M | $2.71M | $1.43M | $435K | $124K | $54K | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $670K | $0 | $0 | $0 | $50K | $36K | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $385K | $690K | $633K | $524K | $234K | $85K | $44K | $41K | $0 | $0 | $14K | $0 | $0 |
| Total Long-Term Assets | $1.24M | $2.9M | $4.73M | $6.13M | $7.53M | $10.22M | $10.99M | $2.75M | $1.47M | $485K | $161K | $68K | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $168.19M | $155.88M | $28.27M | $66.31M | $107.73M | $102.29M | $49.14M | $46.99M | $66.98M | $17.89M | $12.88M | $6.6M | $306K | $545 |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $2.21M | $4.79M | $3.18M | $2.17M | $1.78M | $7.38M | $11.09M | $6.35M | $3.13M | $3.42M | $1.31M | $344K | $181K | $50 |
| Short-Term Debt | $0 | $0 | $16.21M | $3.15M | $3.86M | $710K | $753K | $394K | $333K | $272K | $162K | $144K | $307K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.46M | $0 | $1.94M | $1.59M | $0 | $141K | $0 |
| Other Current Liabilities | $2.86M | $2.28M | $39K | $37K | $134K | $797K | $3.67M | $7.63M | $0 | $789K | $0 | $0 | $20K | $227 |
| Total Current Liabilities | $20.69M | $11.82M | $31.89M | $12.64M | $17.01M | $31.9M | $34.89M | $18.09M | $8.2M | $8.9M | $3.63M | $738K | $649K | $277 |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $15.98M | $15.64M | $18.03M | $0 | $0 | $0 | $0 | $0 | $0 | $331K | $467 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $260K | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $44K | $22K | $22K | $0 | $0 | $1.38M | $990K | $66K | $0 | $0 | $1.11M | -$467 |
| Total Long-Term Liabilities | $0 | $1.63M | $3.28M | $20.68M | $21.61M | $25.12M | $8.1M | $1.38M | $990K | $70K | $260K | $0 | $1.44M | $467 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$0 |
| Total Liabilities | $20.69M | $13.45M | $35.18M | $33.32M | $38.62M | $57.02M | $42.98M | $19.47M | $9.19M | $8.97M | $3.89M | $738K | $2.09M | $743 |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.11M | $989 |
| Common Stock | $2K | $1K | $0 | $417 | $13K | $10K | $6K | $6K | $6K | $4K | $4K | $3K | $696 | $1 |
| Retained Earnings | -$555.43M | -$476.89M | -$436.68M | -$392.08M | -$349.73M | -$304.09M | -$192.82M | -$121.37M | -$65.7M | -$33.28M | -$13.28M | -$4.43M | -$1.89M | -$1K |
| Comprehensive Income & Other | -$53K | $35K | -$1K | -$126K | -$62K | $0 | $0 | -$667K | -$364K | -$108K | -$54K | -$10K | -$1.11M | $0 |
| Other Stockholders' Equity | $702.93M | $619.32M | $429.78M | $425.07M | $418.83M | $349.36M | $198.98M | $148.89M | $123.48M | $42.19M | $22.26M | $10.29M | $103K | $1K |
| Total Equity | $147.5M | $142.43M | -$6.91M | $32.99M | $69.11M | $45.27M | $6.16M | $27.52M | $57.78M | $8.92M | $8.99M | $5.86M | -$1.78M | -$198 |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $168.19M | $155.88M | $28.27M | $66.31M | $107.73M | $102.29M | $49.14M | $46.99M | $66.98M | $17.89M | $12.88M | $6.6M | $306K | $545 |
| Supplementary Data | ||||||||||||||
| Total Debt | $1.63M | $3.24M | $20.89M | $25.09M | $26.59M | $26.84M | $9.45M | $394K | $333K | $276K | $162K | $144K | $638K | $0 |
| Net Debt | -$26.86M | -$13.96M | $7.16M | $8.09M | $1.58M | -$58.6M | -$22.3M | -$41.35M | -$62.2M | -$14.72M | -$12.18M | -$6.12M | $335K | -$542 |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Operating Activities | ||||||||||||||
| Net Income | -$78.54M | -$40.21M | -$44.6B | -$42.35M | -$45.64M | -$111.27M | -$71.45M | -$55.67M | -$32.42M | -$20M | -$8.85M | -$2.54M | -$602K | -$887 |
| Depreciation & Amortization | $233K | $588K | $641K | $1.49M | $1.64M | $1.69M | $1.23M | $494K | $256K | $88K | $44K | $10K | $557K | $824 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $70K | -$8K | $14K | $0 | $24K | $0 | $0 |
| Stock-Based Compensation | $6.29M | $6.14M | $3.47B | $5.72M | $9.48M | $12.46M | $11.98M | $7.61M | $5.69M | $3.16M | $1.15M | $193K | $6K | $26 |
| Changes in Working Capital: | ||||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $1.62M | $1.06M | $2.32M | $12.5M | $1M | -$1M | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5.39M | -$404K | $2.11M | $0 | $0 | $0 | $0 |
| Accounts Payable | -$2.35M | $1.6M | $1.03B | -$257K | -$5.96M | -$3.47M | $4.37M | $3.9M | -$886K | $1.89M | $972K | $170K | $132K | $0 |
| Other Working Capital | $11.47M | -$7.18M | $2.04B | -$3.77M | -$11.36M | -$799K | $5.79M | -$4.79M | -$1.94M | $89K | $2.04M | -$96K | $33K | $0 |
| Total Working Capital Change | $9.12M | -$5.58M | $3.07B | -$4.02M | -$15.7M | -$3.2M | $12.48M | $17.01M | -$2.23M | $3.09M | $3.01M | $74K | $165K | $0 |
| Other Non-Cash Items | -$1.59M | -$2.74M | $1.97B | $1.62M | $2.03M | $636K | $46K | $422K | $914K | $76K | -$2K | -$123K | -$493K | -$733 |
| Net Cash from Operating | -$64.49M | -$41.79M | -$36.1B | -$37.54M | -$48.18M | -$99.69M | -$45.72M | -$30.07M | -$27.8M | -$13.57M | -$4.65M | -$2.36M | -$367K | -$770 |
| Investing Activities | ||||||||||||||
| Capital Expenditures | -$7K | $0 | $0 | -$13K | -$54K | -$484K | -$2.74M | -$2.3M | -$707K | -$353K | -$114K | -$64K | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $8K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$163.09M | -$180.8M | -$33.88B | -$86.34M | -$87.27M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $161.46M | $59.49M | $69.53B | $116.42M | $13.88M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $24K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$1.64M | -$121.31M | $35.64B | $30.07M | -$73.42M | -$484K | -$2.74M | -$2.3M | -$707K | -$353K | -$114K | -$64K | $0 | $0 |
| Financing Activities | ||||||||||||||
| Debt Repaid | - | $15.18M | $2.82B | $119K | - | -$18.76M | -$358K | -$57K | -$57K | -$107K | -$18K | $55K | -$7K | - |
| Common Stock Issuance | $77.43M | $182.06M | $244.3M | $0 | $62.59M | $136.16M | $40.68M | $12.05M | $78.89M | $16.7M | $11.33M | $10.31M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | -$190.9M | $0 | -$1.82M | $0 | -$2.57M | -$690K | -$2.94M | $0 | -$509K | -$1.92M | $120K | $1K |
| Net Cash from Financing | $77.43M | $166.58M | -$2.82B | -$534K | $60.82M | $154.87M | $38.46M | $11.42M | $76.01M | $16.74M | $10.84M | $8.39M | $127K | $1K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | -$670K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $11.29M | $3.47M | -$3.28B | -$8M | -$60.78M | $54.03M | -$10M | -$20.95M | $47.5M | $2.82M | $6.08M | $5.96M | -$239K | $273 |
| Supplementary Data | ||||||||||||||
| Operating Cash Flow | -$64.49M | -$41.79M | -$36.1B | -$37.54M | -$48.18M | -$99.69M | -$45.72M | -$30.07M | -$27.8M | -$13.57M | -$4.65M | -$2.36M | -$367K | -$770 |
| Capital Expenditure | -$7K | $0 | $0 | -$13K | -$54K | -$484K | -$2.74M | -$2.3M | -$707K | -$353K | -$114K | -$64K | $0 | $0 |
| Free Cash Flow | -$64.5M | -$41.79M | -$36.1B | -$37.56M | -$48.24M | -$100.17M | -$48.46M | -$32.37M | -$28.5M | -$13.92M | -$4.76M | -$2.43M | -$367K | -$770 |
| Cash at Beginning | $17.87M | $14.39M | $17.67B | $25.68M | $86.45M | $31.75M | $41.75M | $62.7M | $15.19M | $12.37M | $6.26M | $303K | $542K | $270 |
| Cash at End | $29.16M | $17.87M | $14.39B | $17.67M | $25.68M | $85.78M | $31.75M | $41.75M | $62.7M | $15.19M | $12.34M | $6.26M | $303K | $542 |